HRMY

Harmony Biosciences Holdings (HRMY)

US
$ 39.0753.26%

Price Chart

Key Statistics

Market Cap
$ 1.88B
P/E Ratio
12.50
Revenue (TTM)
$ 744.85M
Volume
599.86K
52W High
$ 41.61
52W Low
$ 26.47
Dividend Yield
0.00%
Beta
0.87

Technicals

50-Day MA
33.123
200-Day MA
34.2731
52 Week High
41.61
52 Week Low
26.47

About HRMY

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United .

Employees
268
Headquarters
Plymouth Meeting, PA
CEO
Mr. Jeffrey S. Aronin

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg